Skip to main content

Table 2 Clinical labels found enriched in multi-to-multi (MtoM) scenario consensus clusters, in single-to-multi (StoM All) scenario consensus clusters, and for both scenarios

From: Consensus clustering applied to multi-omics disease subtyping

Cancer Scenarios Enriched clinical labels
AML Both Age at initial pathologic diagnosis
CALGB cytogenetics risk category
Leukemia French–American–”British Morphology Code
BIC Both Age at initial pathologic diagnosis, PAM50 call
Pathologic N, Pathologic Stage, Histological type
Estrogen receptor status, Progesterone receptor status
StoM All Pathologic M, Pathologic T
COAD MtoM Histological type
StoM All Age at initial pathologic diagnosis
GBM Both None
KIRC Both Pathologic M, Neoplasm histologic grade
StoM All Pathologic T
LIHC Both Gender, Age at initial pathologic diagnosis, Fetoprotein outcome value
LUSC Both None
OV Both None
SARC Both Gender, Age at initial pathologic diagnosis, Histological type
MtoM New neoplasm event type
SKCM MtoM Age at initial pathologic diagnosis